Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01296256Phase 2Completed
Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).
Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more
Principalinvestigator

Research Network

Collaboration Network

28 collaborators·73 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hospital Arnau de Vilanova de Valencia

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Carlos Grande, MD

Hospital Universitario 12 de Octubre

Moderately Similar
1 trials

Shared therapeutic areas:

Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more

Worked with same sponsors:

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Collaborated on 1 trial
Similarity Score44%

Miguel Ángel Canales, MD

Hospital Universitario La Paz

Moderately Similar
1 trials

Shared therapeutic areas:

Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more

Worked with same sponsors:

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Collaborated on 1 trial
Similarity Score44%

Luis Palomera, MD

Hospital Clínico de Zaragoza "Lozano Blesa"

Moderately Similar
1 trials

Shared therapeutic areas:

Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more

Worked with same sponsors:

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Collaborated on 1 trial
Similarity Score44%

José Rifón, MD

Clínica Universitaria Navarra

Moderately Similar
1 trials

Shared therapeutic areas:

Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more

Worked with same sponsors:

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Collaborated on 1 trial
Similarity Score44%

Mª José Terol, MD

Hospital Clínico de Valencia

Moderately Similar
1 trials

Shared therapeutic areas:

Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more

Worked with same sponsors:

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Collaborated on 1 trial
Similarity Score44%

Ana Pilar González, MD

Hospital Central de Asturias

Moderately Similar
1 trials

Shared therapeutic areas:

Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more

Worked with same sponsors:

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Collaborated on 1 trial
Similarity Score44%

Eulogio Conde, MD

Hospital Marqués de Valdecilla

Moderately Similar
1 trials

Shared therapeutic areas:

Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more

Worked with same sponsors:

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Collaborated on 1 trial
Similarity Score44%

Raquel del Campo, MD

Hospital Son Llátzer

Moderately Similar
1 trials

Shared therapeutic areas:

Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more

Worked with same sponsors:

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Collaborated on 1 trial
Similarity Score44%

Armando López, MD

Hospial Clínic de Barcelona

Moderately Similar
1 trials

Shared therapeutic areas:

Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more

Worked with same sponsors:

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Collaborated on 1 trial
Similarity Score44%

Mª Dolores Caballero, MD

University of Salamanca

Moderately Similar
1 trials

Shared therapeutic areas:

Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more

Worked with same sponsors:

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Collaborated on 1 trial
Similarity Score44%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01296256Phase 2PrincipalInvestigator

Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).

Aggressive Non Hodgkin's LymphomaAutologous Stem Cell TransplantBendamustine+1 more
Completed

All 1 trials loaded